CID 6444692

Mubritinib

Structural Information

Molecular Formula
C25H23F3N4O2
SMILES
C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)/C=C/C4=CC=C(C=C4)C(F)(F)F
InChI
InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+
InChIKey
ZTFBIUXIQYRUNT-MDWZMJQESA-N
Compound name
4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

26
References

7719
Patents

468.1773 Da
Monoisotopic Mass

5.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 469.18458 210.9
[M+Na]+ 491.16652 222.2
[M+NH4]+ 486.21112 213.4
[M+K]+ 507.14046 218.3
[M-H]- 467.17002 211.7
[M+Na-2H]- 489.15197 217.2
[M]+ 468.17675 212.5
[M]- 468.17785 212.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe